loadpatents
name:-0.027378082275391
name:-0.021152019500732
name:-0.0016200542449951
Colotta; Francesco Patent Filings

Colotta; Francesco

Patent Applications and Registrations

Patent applications and USPTO patent grants for Colotta; Francesco.The latest application filed is for "use of 1,25-dihydroxyvitamin d values in ratio with pth as a prognostic biomarker".

Company Profile
2.24.25
  • Colotta; Francesco - Segrate IT
  • Colotta; Francesco - Segrate Milano
  • Colotta; Francesco - Milan IT
  • Colotta; Francesco - L'Aquila IT
  • Colotta; Francesco - I-67100 L'Aquila AQ IT
  • Colotta; Francesco - I-67100 L'Aquila IT
  • Colotta, Francesco - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker
Grant 10,983,136 - Colotta , et al. April 20, 2
2021-04-20
Use of 1,25-Dihydroxyvitamin D Values in Ratio with PTH as a Prognostic Biomarker
App 20210072264 - Colotta; Francesco ;   et al.
2021-03-11
Use of 1,25-Dihydroxyvitamin D Values in Ratio with PTH as a Prognostic Biomarker
App 20170322230 - Colotta; Francesco ;   et al.
2017-11-09
Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
Grant 9,493,402 - Allegretti , et al. November 15, 2
2016-11-15
Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
Grant 9,328,057 - Allegretti , et al. May 3, 2
2016-05-03
2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
Grant 8,871,784 - Moriconi , et al. October 28, 2
2014-10-28
2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
Grant 8,648,110 - Moriconi , et al. February 11, 2
2014-02-11
"omega-aminoalkylamides Of R-2-aryl-propionic Acids Asinhibitors Of The Chemotaxis Of Polymorphonucleate Andmononucleate Cells"
App 20130079514 - ALLEGRETTI; Marcello ;   et al.
2013-03-28
2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
Grant 8,293,788 - Allegretti , et al. October 23, 2
2012-10-23
2-phenylpropionic Acid Derivatives And Pharmaceutical Compositions Containing Them
App 20120004264 - Allegretti; Marcello ;   et al.
2012-01-05
2-aryl-propionic acids and pharmaceutical compositions containing them
Grant 8,063,242 - Allegretti , et al. November 22, 2
2011-11-22
2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
Grant 8,039,656 - Allegretti , et al. October 18, 2
2011-10-18
2-aryl-acetic Acids, Their Derivatives And Pharmaceutical Compositions Containing Them
App 20110195967 - MORICONI; Alessio ;   et al.
2011-08-11
2-arylpropionic acid derivatives and pharmaceutical compositions containing them
Grant 7,939,521 - Allegretti , et al. May 10, 2
2011-05-10
2-aryl-acetic Acids, Their Derivatives And Pharmaceutical Compositions Containing Them
App 20100267726 - MORICONI; Alessio ;   et al.
2010-10-21
2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
Grant 7,776,909 - Moriconi , et al. August 17, 2
2010-08-17
Sulfonic acids, their derivatives and pharmaceutical compositions containing them
Grant 7,737,139 - Allegretti , et al. June 15, 2
2010-06-15
Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils
Grant 7,705,050 - Allegretti , et al. April 27, 2
2010-04-27
Amidines and derivatives thereof and pharmaceutical compositions containing them
Grant 7,674,806 - Allegretti , et al. March 9, 2
2010-03-09
2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
App 20090203740 - Allegretti; Marcello ;   et al.
2009-08-13
Chiral Arylketones In The Treatment Of Neutrophil-dependent Inflammatory Diseases
App 20090203652 - ALLEGRETTI; Marcello ;   et al.
2009-08-13
Use of (R)--ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs
Grant 7,560,487 - Bertini , et al. July 14, 2
2009-07-14
Metabolites Of 2-Arylpropionic Acid Derivatives And Pharmaceutical Compositions Containing Them
App 20090131441 - Bertini; Riccardo ;   et al.
2009-05-21
Use of n-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury
App 20090030083 - Bertini; Riccardo ;   et al.
2009-01-29
2-Arylpropionic Acid Derivatives and Pharmaceutical Compositions Containing Them
App 20080312293 - Allegretti; Marcello ;   et al.
2008-12-18
Omega-aminoalkylamides Of R-2-aryl-propionic Acids As Inhibitors Of The Chemotaxis Of Polymorphonucleate And Mononucleate Cells
App 20080045522 - ALLEGRETTI; Marcello ;   et al.
2008-02-21
Tumor-Homing Cells Engineered to Produce Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (Trail) by Adenoviral-Mediated Gene Transfer
App 20070264231 - Gianni; Alessandro Massimo ;   et al.
2007-11-15
Amidines and derivatives thereof and pharmaceutical compositions containing them
App 20070155717 - Allegretti; Marcello ;   et al.
2007-07-05
Amide of R-2-(aminoaryl)-propionic acid for use in the prevention of leucocyte activation
Grant 7,217,707 - Allegretti , et al. May 15, 2
2007-05-15
Pharmaceutical combination useful for stem cell mobilization
App 20070036747 - Gianni; Alessandro Massimo ;   et al.
2007-02-15
Sulfonic acids, their derivatives and pharmaceutical compositions containing them
App 20060258730 - Allegretti; Marcello ;   et al.
2006-11-16
Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
App 20060247297 - Allegretti; Marcello ;   et al.
2006-11-02
2-Aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
App 20060223842 - Moriconi; Alessio ;   et al.
2006-10-05
N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
Grant 6,887,903 - Bertini , et al. May 3, 2
2005-05-03
N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
Grant 6,881,755 - Bertini , et al. April 19, 2
2005-04-19
Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
App 20050080067 - Allegretti, Marcello ;   et al.
2005-04-14
2-Aryl-propionic acids and pharmaceutical compositions containing them
App 20050038119 - Allegretti, Marcello ;   et al.
2005-02-17
Amide of r-2-(aminoaryl)-propionic acid for use in theprevention of leucocyte activation
App 20040186146 - Allegretti, Marcello ;   et al.
2004-09-23
Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils
App 20040181073 - Allegretti, Marcelo ;   et al.
2004-09-16
Use of (r) - ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs
App 20040102520 - Bertini, Riccardo ;   et al.
2004-05-27
N - ( 2 - aryl - propionyl ) - sulfonamides and pharmaceutical preparations containing them
App 20030216392 - Bertini, Riccardo ;   et al.
2003-11-20
Benzyloxy Prodigiosine Compounds
App 20020049248 - D'ALESSIO, ROBERTO ;   et al.
2002-04-25
Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole compound
Grant 6,291,509 - Ferrari , et al. September 18, 2
2001-09-18
Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
Grant 6,071,947 - D'Alessio , et al. June 6, 2
2000-06-06
Antibodies to intereleukin-1 antagonists
Grant 5,981,713 - Colotta , et al. November 9, 1
1999-11-09
Interleukin-1 antagonist
Grant 5,739,282 - Colotta , et al. April 14, 1
1998-04-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed